Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
NeoGenomics Q1 EPS $(0.020) Misses $0.020 Estimate, Sales $106.030M Beat $104.580M Estimate
11:19am, Tuesday, 28'th Apr 2020NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter
11:00am, Tuesday, 28'th Apr 2020
First-Quarter 2020 Highlights: Consolidated revenue increased 10.9% to $106.0 million Clinical Services revenue increased 7.9% to $93.0 million Pharma Services revenue increased 39.3% to $13.0 million
NeoGenomics (NEO) Reports Q1 Loss, Misses Revenue Estimates
12:00am, Tuesday, 28'th Apr 2020NeoGenomics Q1 2020 Earnings Preview
09:30pm, Monday, 27'th Apr 2020
NeoGenomics (NASDAQ:NEO) is scheduled to announce Q1 earnings results on Tuesday, April 28th, before market open.The consensus EPS Estimate is $0.02 (-71.4% Y/Y) and the consensus Revenue Estimate is
Here's Why Invitae Stock Popped as Much as 13.2% Today
08:00pm, Monday, 27'th Apr 2020
A rising tide lifts all ships.
Interview with Vid Gradisar, CEO of Crypto Education Platform Newscrypto
09:34am, Monday, 27'th Apr 2020
Vid Gradisar, CEO of NewsCrypto.io, shared his views on the future of the industry and explained why NewsCrypto.io stands out from the crowd.
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
08:37pm, Sunday, 26'th Apr 2020
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week, with Immunomedics, Inc.'s
The Most Important Thing to Watch When NeoGenomics Reports Earnings
06:06pm, Sunday, 26'th Apr 2020
Test volumes fell by double digits at the end of March compared with the year-ago period. How long does management think that trend will continue?
Stephens Begins Coverage on NeoGenomics (NASDAQ:NEO)
08:52am, Saturday, 25'th Apr 2020
Stephens initiated coverage on shares of NeoGenomics (NASDAQ:NEO) in a report released on Tuesday morning, BenzingaRatingsTable reports. The brokerage issued an overweight rating and a $33.00 price ob
Stephens & Co. Reinstates Overweight on NeoGenomics, Announces $33 Price Target
11:21am, Tuesday, 21'st Apr 2020UBS softens view on Eli Lilly in premarket analyst action
11:14am, Tuesday, 21'st Apr 2020
Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with an Outperform rating and an $8 (21% upside) price target at RBC.Aprea Therapeutics (NASDAQ:APRE) initiated with an Outperform rating and a
NeoGenomics (NEO) to Release Earnings on Tuesday
05:44am, Tuesday, 21'st Apr 2020
NeoGenomics (NASDAQ:NEO) is set to release its earnings data before the market opens on Tuesday, April 28th. NeoGenomics has set its FY 2020 Pre-Market guidance at EPS.Individual interested in partici
NeoGenomics, Inc. (NASDAQ:NEO) Expected to Post Quarterly Sales of $106.05 Million
07:40am, Monday, 20'th Apr 2020
Equities research analysts expect NeoGenomics, Inc. (NASDAQ:NEO) to post sales of $106.05 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estima
$0.02 EPS Expected for NeoGenomics, Inc. (NASDAQ:NEO) This Quarter
08:40am, Saturday, 18'th Apr 2020
Equities research analysts expect that NeoGenomics, Inc. (NASDAQ:NEO) will announce earnings per share of $0.02 for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Ne
